Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19

N. Horowitz, B. Brenner,

2021

https://doi.org/10.1055/s-0040-1714275

Цитирование

Об авторах

N. Horowitz
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
B. Brenner
Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel

Название журнала

Том

Выпуск

Страницы

Ключевые слова

anticoagulant agent; interleukin 1; tumor necrosis factor; anticoagulant agent; fibrinolytic agent; thromboplastin; all cause mortality; anticoagulation; cancer patient; coronavirus disease 2019; hemostasis; human; inferior cava vein; malignant neoplasm; Note; pathogenesis; priority journal; thrombosis; thrombosis prevention; venous thromboembolism; Betacoronavirus; blood; complication; Coronavirus infection; cytokine release syndrome; exosome; extracellular trap; intermittent pneumatic compression device; neoplasm; pandemic; pathophysiology; physiology; risk; thrombophilia; thrombosis; vascular endothelium; venous thromboembolism; virus pneumonia; Anticoagulants; Betacoronavirus; Coronavirus Infections; Cytokine Release Syndrome; Endothelium, Vascular; Extracellular Traps; Extracellular Vesicles; Fibrinolytic Agents; Hemostasis; Humans; Intermittent Pneumatic Compression Devices; Neoplasms; Pandemics; Pneumonia, Viral; Risk; Thrombophilia; Thromboplastin; Thrombosis; Venous Thromboembolism

Издатель

Тип документа

Источник